Mydecine Innovations Group, Inc. released its earnings results on Nov 20, 2024. The company reported -C$0.032 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.032.

Q: Is Mydecine Innovations Group, Inc. overvalued?

According to Wall Street analysts Mydecine Innovations Group, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: How many shares outstanding does Mydecine Innovations Group, Inc. have?

Mydecine Innovations Group, Inc. has 61,755,398 shares outstanding.

Q: What happened to Mydecine Innovations Group, Inc.’s price movement after its last earnings report?

Mydecine Innovations Group, Inc. reported an EPS of -C$0.032 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Compare

97 Followers

MYCO Stock Chart & Stats

Day’s Range― - ―

52-Week Range<C$0.01 - C$0.03

Previous CloseN/A

Volume181.87K

Average Volume (3M)16.10K

Market Cap

C$617.55K

Enterprise ValueC$7.09M

Total Cash (Recent Filing)11.09K

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta3.35

Next Earnings

Mar 28, 2025

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.27

Shares Outstanding61,755,398

10 Day Avg. Volume668

30 Day Avg. Volume16,096

Standard Deviation0.43

R-Squared0.08

Alpha-0.13

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

Price to Cash Flow (P/CF)3.10

P/FCF Ratio0.40

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

---

Mydecine Innovations Group News

PremiumCompany Announcements

Mydecine Shares Suspended on Aquis Market

4M ago

PremiumCompany Announcements

Mydecine Completes Key Financial Filings

8M ago

PremiumCompany Announcements

Mydecine Delays Financial Filings, Postpones AGM

8M ago

PremiumCompany Announcements

Mydecine Delays Financial Reports, Trades Continue

9M ago

PremiumCompany Announcements

Mydecine Reports Delay and Progress Amid MCTO

9M ago

PremiumCompany Announcements

Mydecine Requests Extra Time for Financial Filings

10M ago

PremiumCompany Announcements

Mydecine Innovations Faces Trading Restrictions

10M ago

PremiumCompany Announcements

Mydecine Announces Restructuring and CEO Investment

10M ago

See All TSE:MYCO News

---

Financials

Quarterly

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

― Insiders

― Mutual Funds

<0.01% Other Institutional Investors

100.00% Public Companies and

Individual Investors

Detailed Ownership Overview >

MYCO FAQ

What was Mydecine Innovations Group, Inc.’s price range in the past 12 months?

Mydecine Innovations Group, Inc. lowest stock price was <C$0.01 and its highest was C$0.03 in the past 12 months.

What is Mydecine Innovations Group, Inc.’s market cap?

Mydecine Innovations Group, Inc.’s market cap is C$617.55K.

When is Mydecine Innovations Group, Inc.’s upcoming earnings report date?

Mydecine Innovations Group, Inc.’s upcoming earnings report date is Mar 28, 2025 which is in 35 days.

How were Mydecine Innovations Group, Inc.’s earnings last quarter?

Mydecine Innovations Group, Inc. released its earnings results on Nov 20, 2024. The company reported -C$0.032 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.032.

Is Mydecine Innovations Group, Inc. overvalued?

According to Wall Street analysts Mydecine Innovations Group, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Mydecine Innovations Group, Inc. pay dividends?

Mydecine Innovations Group, Inc. does not currently pay dividends.

What is Mydecine Innovations Group, Inc.’s EPS estimate?

Mydecine Innovations Group, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Mydecine Innovations Group, Inc. have?

Mydecine Innovations Group, Inc. has 61,755,398 shares outstanding.

What happened to Mydecine Innovations Group, Inc.’s price movement after its last earnings report?

Mydecine Innovations Group, Inc. reported an EPS of -C$0.032 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Mydecine Innovations Group, Inc.?

Currently, no hedge funds are holding shares in TSE:MYCO

---

Company Description

Mydecine Innovations Group, Inc.

Mydecine Innovations Group Inc is a biopharma and life sciences company. It is committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use. Reinforcing Mydecine's commitment to mental health solutions is underpinned by the company's three main focuses: Clinical Trials focusing on Veterans, EMS, and First Responders with a PTSD indication; Research and Development building a robust portfolio of intellectual property around drug discovery and unique delivery mechanisms with relevant use patents and future patent applications and Modern technology utilizing for better clinical trial management and mental health wellbeing.

---